Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects
This study has been completed.
Study NCT01404091   Information provided by Eli Lilly and Company

First Received on July 26, 2011.   Last Updated on January 20, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depression
Additional conditions recognized in this trial
Depressive Disorder
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
LY2940094
Additional drug interventions recognized in this trial
Nociceptin
More general drug interventions related to this trial
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services